Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: The Japanese childhood acute myeloid leukaemia cooperative study

British Journal of Haematology

Volumn 152, Issue 1, 2011, Pages 89-98

  Imaizumi, Masue ^a   Tawa, Akio ^b   Hanada, Ryoji ^c   Tsuchida, Masahiro ^d   Tabuchi, Ken ^e   Kigasawa, Hisato ^e   Kobayashi, Ryoji ^f   Morimoto, Akira ^g   Nakayama, Hideki ^h   Hamamoto, Kazuko ⁱ   Kudo, Kazuko ^j   Yabe, Hiromasa ^k   Horibe, Keizo ^l   Tsuchiya, Shigeru ^m   Tsukimoto, Ichiro ⁿ  

^a MIYAGI CHILDREN S HOSPITAL   (Japan)

^b OSAKA NATIONAL HOSPITAL   (Japan)

^c SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^d Ibaraki Children's Hospital   (Japan)

^e KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

^f SAPPORO HOKUYU HOSPITAL   (Japan)

^g JICHI MEDICAL UNIVERSITY   (Japan)

^h FUKUOKA HIGASHI MEDICAL CENTER   (Japan)

ⁱ ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^j SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

^k TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^m TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

more..

Author keywords

All trans retinoic acid; Anthracyclines; Childhood acute promyelocytic leukaemia; Cytarabine; Long term prognosis

Indexed keywords

ACLARUBICIN; ANTHRACYCLINE DERIVATIVE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; HYDROCORTISONE; METHOTREXATE; MITOXANTRONE; PIRARUBICIN; RETINOIC ACID;

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; BLEEDING; BRAIN PSEUDOTUMOR; CANCER INCIDENCE; CANCER REGRESSION; CANCER RELAPSE; CARDIOTOXICITY; CHILD; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSURIA; EVENT FREE SURVIVAL; FEMALE; HEALTH SURVEY; HUMAN; INFANT; INJECTION SITE INFECTION; INJECTION SITE PAIN; KIDNEY FAILURE; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE CYCLE TREATMENT; NAUSEA; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROSPECTIVE STUDY; RESPIRATORY DISTRESS; RETINOIC ACID SYNDROME; SCHOOL CHILD; SEPSIS; TREATMENT DURATION;

ADOLESCENT; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CYTARABINE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKOCYTE COUNT; MALE; NEOPLASM, RESIDUAL; NEUTROPENIA; PROGNOSIS; RECURRENCE; TREATMENT OUTCOME; TRETINOIN;

EID: 78650006148     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08332.x     Document Type: Article

References (36)

1. Adès, L., Chevret, S., Raffoux, E., De Botton, S., Guerci, A., Pigneux, A., Stoppa, A.M., Lamy, T., Rigal-Huguet, F., Vekhoff, A., Meyer-Monard, S., Maloisel, F., Deconinck, E., Ferrant, A., Thomas, X., Fegueux, N., Chomienne, C., Dombret, H., Degos, L. & Fenaux, P. (2006) European Acute Promyelocytic Leukemia Group. Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group. Journal of Clinical Oncology, 24, 5703-5710.
2. Adès, L., Sanz, M.A., Chevret, S., Montesinos, P., Chevallier, P., Raffoux, E., Vellenga, E., Guerci, A., Pigneux, A., Huguet, F., Rayon, C., Stoppa, A.M., De La Serna, J., Cahn, J.Y., Meyer-Monard, S., Pabst, T., Thomas, X., De Botton, S., Parody, R., Bergua, J., Lamy, T., Vekhoff, A., Negri, S., Ifrah, N., Dombret, H., Ferrant, A., Bron, D., Degos, L. & Fenaux, P. (2008) Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results. Blood, 111, 1078-1084.
3. Adès, L., Guerci, A., Raffoux, E., Sanz, M., Chevallier, P., Lapusan, S., Recher, C., Thomas, X., Rayon, C., Castaigne, S., Tournilhac, O., De Botton, S., Ifrah, N., Cahn, J.Y., Solary, E., Gardin, C., Fegeux, N., Bordessoule, D., Ferrant, A., Meyer-Monard, S., Vey, N., Dombret Degos, H.L., Chevret, S. & Fenaux, P. (2010) European APL Group. Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience. Blood, 115, 1690-1696.
4. Bagnes, C., Panchuk, P.N. & Recondo, G. (2010) Antineoplastic chemotherapy induced QTc prolongation. Current Drug Safety, 5, 93-96.
5. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
6. De Botton, S., Coiteux, V., Chevret, S., Rayon, C., Vilmer, E., Sanz, M., De La Serna, J., Philippe, N., Baruchel, A., Leverger, G., Robert, A., San Miguel, J., Conde, E., Sotto, J.J., Bordessoule, D., Fegueux, N., Fey, M., Parry, A., Chomienne, C., Degos, L. & Fenaux, P. (2004) Outcome of childhood acute promyelocytic leukemia wit all-trans-retinoic acid and chemotherapy. Journal of Clinical Oncology, 22, 1404-1412.
7. De Botton, S., Sanz, M.A., Chevret, S., Dombret, H., Martin, G., Thomas, X., Mediavilla, J.D., Recher, C., Ades, L., Quesnel, B., Brault, P., Fey, M., Wandt, H., Machover, D., Guerci, A., Maloisel, F., Stoppa, A.M., Rayon, C., Ribera, J.M., Chomienne, C., Degos, L., Fenaux, P.; European APL Group & PETHEMA Group. (2006) Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia, 20, 35-41.
8. Breccia, M., Carmosino, I., Diverio, D., De Santis, S., De Propris, M.S., Romano, A., Petti, M.C., Mandelli, F. & Lo-Coco, F. (2003) Early detection of meningeal localization in acute promyelocytic leukaemia patients with high presenting leucocyte count. British Journal of Haematology, 120, 266-270.
9. Chow, J. & Feusner, J. (2009) Isolated central nervous system recurrence of acute promyelocytic leukemia in children. Pediatric Blood & Cancer, 52, 11-13.
10. Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., Fey, M., Rayon, C., Huguet, F., Sotto, J.J., Gardin, C., Makhoul, P.C., Travade, P., Solary, E., Fegueux, N., Bordessoule, D., Miguel, J.S., Link, H., Desablens, B., Stamatoullas, A., Deconinck, E., Maloisel, F., Castaigne, S., Preudhomme, C. & Degos, L. (1999) A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group Blood, 94, 1192-1200.
11. Ferrara, F. (2010) Acute promyelocytic leukemia: what are the treatment options? Expert Opinion on Pharmacotherapy, 11, 587-596.
12. Grignani, F., Fagioli, M., Alcalay, M., Longo, L., Pandolfi, P.P., Donti, E., Biondi, A., Lo Coco, F., Grignani, F. & Pelicci, P.G. (1994) Acute promyelocytic leukemia: from genetics to treatment. Blood, 83, 10-25.
13. Guglielmi, C., Martelli, M.P., Diverio, D., Fenu, S., Vegna, M.L., Cantù-Rajnoldi, A., Biondi, A., Cocito, M.G., Del Vecchio, L., Tabilio, A., Avvisati, G., Basso, G. & Lo Coco, F. (1998) Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. British Journal of Haematology, 102, 1035-1041.
14. Ko, B.S., Tang, J.L., Chen, Y.C., Yao, M., Wang, C.H., Shen, M.C. & Tien, H.F. (1999) Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia - the occurrence of retinoic acid syndrome is a risk factor. Leukemia, 13, 1406-1408.
15. Le Deley, M.C., Leblanc, T., Shamsaldin, A., Raquin, M.A., Lacour, B., Sommelet, D., Chompret, A., Cayuela, J.M., Bayle, C., Bernheim, A., De Vathaire, F., Vassal, G., Hill, C. & Société Française d'Oncologie Pédiatrique. (2003) Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique. Journal of Clinical Oncology, 21, 1074-1081.
16. Lenk, H., Tanneberger, S., Wiener, N., Giesske, H., Gärtner, S., Geyer, J. & Rotte, K.H. (1990) Phase II study of pirarubicin (THP-adriamycin) in metastatic breast cancer patients. Oncology, 47, 97-100.
17. Liso, V., Specchia, G., Pogliani, E.M., Palumbo, G., Mininni, D., Rossi, V., Teruzzi, E., Mestice, A., Coppi, M.R. & Biondi, A. (1998) Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases. Cancer, 83, 1522-1528.
18. Mann, G., Reinhardt, D., Ritter, J., Hermann, J., Schmitt, K., Gadner, H. & Creutzig, U. (2001) Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children. Annals of Hematology, 80, 417-422.
19. Nysom, K., Holm, K., Lipsitz, S.R., Mone, S.M., Colan, S.D., Orav, E.J., Sallan, S.E., Olsen, J.H., Hertz, H., Jacobsen, J.R. & Lipshultz, S.E. (1998) Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 16, 545-550.
20. Ortega, J.J., Madero, L., Martín, G., Verdeguer, A., García, P., Parody, R., Fuster, J., Molines, A., Novo, A., Debén, G., Rodríguez, A., Conde, E., De La Serna, J., Allegue, M.J., Capote, F.J., González, J.D., Bolufer, P., González, M., Sanz, M.A. & PETHEMA Group. (2005) Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group. Journal of Clinical Oncology, 23, 7632-7640.
21. Sakata-Yanagimoto, M., Kanda, Y., Nakagawa, M., Asano-Mori, Y., Kandabashi, K., Izutsu, K., Imai, Y., Hangaishi, A., Kurokawa, M., Tsujino, S., Ogawa, S., Chiba, S., Motokura, T. & Hirai, H. (2004) Predictors for severe cardiac complications after hematopoietic stem cell transplantation. Bone Marrow Transplantation, 33, 1043-1047.
22. Sanz, M.A., Lo Coco, F., Martín, G., Avvisati, G., Rayón, C., Barbui, T., Díaz-Mediavilla, J., Fioritoni, G., González, J.D., Liso, V., Esteve, J., Ferrara, F., Bolufer, P., Bernasconi, C., Gonzalez, M., Rodeghiero, F., Colomer, D., Petti, M.C., Ribera, J.M. & Mandelli, F. (2000) Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood, 96, 1247-1253.
23. Sanz, M.A., Martín, G., González, M., León, A., Rayón, C., Rivas, C., Colomer, D., Amutio, E., Capote, F.J., Milone, G.A., De La Serna, J., Román, J., Barragán, E., Bergua, J., Escoda, L., Parody, R., Negri, S., Calasanz, M.J., Bolufer, P. & Programa de Estudio y Traitmiento de las Hemopatías Malignas. (2004) Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group. Blood, 103, 1237-1243.
24. Sanz, M.A., Tallman, M.S. & Lo-Coco, F. (2005) Practice points, consensus, and controversial issues in the management of patients with newly diagnosed acute promyelocytic leukemia. Oncologist, 10, 806-814.
25. Sanz, M.A., Montesinos, P., Vellenga, E., Rayón, C., De La Serna, J., Parody, R., Bergua, J.M., León, A., Negri, S., González, M., Rivas, C., Esteve, J., Milone, G., González, J.D., Amutio, E., Brunet, S., García-Laraña, J., Colomer, D., Calasanz, M.J., Chillón, C., Barragán, E., Bolufer, P. & Lowenberg, B. (2008) Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group. Blood, 112, 3130-3134.
26. Sanz, M.A., Grimwade, D., Tallman, M.S., Lowenberg, B., Fenaux, P., Estey, E.H., Naoe, T., Lengfelder, E., Büchner, T., Döhner, H., Burnett, A.K. & Lo-Coco, F. (2009) Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European Leukemia Net. Blood, 113, 1875-1891.
27. Sanz, M.A., Montesinos, P., Rayón, C., Holowiecka, A., De La Serna, J., Milone, G., De Lisa, E., Brunet, S., Rubio, V., Ribera, J.M., Rivas, C., Krsnik, I., Bergua, J., González, J., Díaz-Mediavilla, J., Rojas, R., Manso, F., Ossenkoppele, G., González, J.D. & Lowenberg, B. (2010) Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood, 115, 5137-5146.
28. Sorensen, K., Levitt, G., Bull, C., Chessells, J. & Sullivan, I. (1997) Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity. Journal of Clinical Oncology, 15, 61-68.
29. Specchia, G., Lo Coco, F., Vignetti, M., Avvisati, G., Fazi, P., Albano, F., Di Raimondo, F., Martino, B., Ferrara, F., Selleri, C., Liso, V. & Mandelli, F. (2001) Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. Journal of Clinical Oncology, 19, 4023-4028.
30. Suzuki, H., Imaizumi, M., Sato, A., Yoshinari, M., Rikiishi, T., Endo, M., Takano, T., Shimizu, T., Hatae, Y., Fujimoto, T., Hayashi, Y. & Iinuma, K. (2001) Monitoring of minimal residual disease in children with acute promyelocytic leukemia by RT-PCR detecting PML/RARalpha chimeric gene: a retrospective study of clinical feasibility. Tohoku Journal of Experimental Medicine, 193, 127-139.
31. Tallman, M.S., Nabhan, C., Feusner, J.H. & Rowe, J.M. (2002) Acute promyelocytic leukemia: evolving therapeutic strategies. Blood, 99, 759-767.
32. Testi, A.M., Biondi, A., Lo Coco, F., Moleti, M.L., Giona, F., Vignetti, M., Menna, G., Locatelli, F., Pession, A., Barisone, E., De Rossi, G., Diverio, D., Micalizzi, C., Aricò, M., Basso, G., Foa, R. & Mandelli, F. (2005) GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood, 106, 447-453.
33. Warrell, Jr, R.P. (1986) Aclacinomycin A. clinical development of a novel anthracycline antibiotic in the haematological cancers. Drugs Under Experimental and Clinical Research, 12, 275-282.
34. Zhang, L., Zhao, H., Zhu, X., Chen, Y., Zou, Y. & Chen, X. (2008) Retrospective analysis of 65 Chinese children with acute promyelocytic leukemia: a single center experience. Pediatric Blood & Cancer, 51, 210-215.
35. Zhou, J., Zhang, Y., Li, J., Li, X., Hou, J., Zhao, Y., Liu, X., Han, X., Hu, L., Wang, S., Zhao, Y., Zhang, Y., Fan, S., Lu, C., Li, L. & Zhu, L. (2010) Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia. Blood, 115, 1697-1702.
36. Zunino, F. & Capranico, G. (1990) DNA topoisomerase II as the primary target of anti-tumor anthracyclines. Anti-Cancer Drug Design, 5, 307-317.